Revenue

BlackSky's new deal validates its high-tech satellite intel, proving its model for turning trials into major contracts in the competitive space-tech market.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

With a new veteran advisor, SpinLaunch pivots to commercialize its Meridian LEO network, aiming for a 'sovereign' niche in the competitive satellite market.

Following a period of explosive growth and strategic acquisitions, NewSpring exits managed IT firm Magna5 in a landmark deal with AEA Investors.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

In a volatile mortgage landscape, this young lender defied trends to surpass $500M in production. Discover the strategy behind their disciplined growth.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

S&P Global unveils 'Mobility Global' for its auto data spin-off, aiming to dominate the $30B market despite a sharp one-day drop in its stock price.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Tractor Beverage's Haymaker line earns a stringent purity certification, signaling a major retail pivot where 'organic' is no longer the final word.

The 'better-for-you' brand is making a massive retail play, adding new executives and launching innovative gummies to capture the $100B energy market.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

UK service provider Kocho partners with Zadara, signaling a broader market shift away from VMware due to rising costs and the growing need for AI readiness.

A new data-driven wellness program in Ontario is dramatically reducing cancer risk for firefighters, offering a blueprint for saving lives and city funds.

A new report reveals AI-powered disinformation is bypassing firewalls, costing billions. Experts say firms are dangerously unprepared for this new reality.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Japan's largest travel agency, JTB, charts a new course for 2035, betting big on AI, global expansion, and sustainability to redefine its future.

Private equity giant AEA Investors acquires a majority stake in Magna5, signaling a major push to scale IT services for businesses under cyber siege.

New multi-year data for Fabry and Pompe disease therapies from Amicus Therapeutics showcases sustained benefits, offering new hope for long-term patient outcomes.

A legacy manufacturer turned decades of dormant engineering files into a strategic asset, recovering 600 hours and boosting efficiency by 98% with AI.